Psoriatic Arthritis Treatment Market (By Drug Class: DMARD, NSAIDs, Biologics, Others; By Product Type: OTC, Prescriptions; By Route of Administration: Oral, Topical, Injectable) - Global Industry Analysis, Market Size, Opportunities and Forecast, 2019 - 2026

Category : Healthcare and Pharmaceuticals | Delivery Format: PDF | Status: Published | Pages : 190

CHAPTER 1. INDUSTRY OVERVIEW

1.1. Definition and Scope
1.1.1. Definition of Psoriatic Arthritis Treatment
1.1.2. Market Segmentation
1.1.3. List of Abbreviations
1.2. Summary
1.2.1. Market Snapshot
1.2.2. Psoriatic Arthritis Treatment Market By Drug Class
1.2.2.1. Global Psoriatic Arthritis Treatment Market Revenue and Growth Rate Comparison By Drug Class (2015-2026)
1.2.2.2. Global Psoriatic Arthritis Treatment Market Revenue Share By Drug Class in 2017
1.2.2.3. DMARD
1.2.2.4. NSAIDs
1.2.2.5. Biologics
1.2.2.6. Others
1.2.3. Psoriatic Arthritis Treatment Market By Product Type
1.2.3.1. Global Psoriatic Arthritis Treatment Market Revenue and Growth Rate Comparison By Product Type (2015-2026)
1.2.3.2. OTC
1.2.3.3. Prescriptions
1.2.4. Psoriatic Arthritis Treatment Market By Route of Administration
1.2.4.1. Global Psoriatic Arthritis Treatment Market Revenue and Growth Rate Comparison By Route of Administration (2015-2026)
1.2.4.2. Oral
1.2.4.3. Topical
1.2.4.4. Injectable
1.2.5. Psoriatic Arthritis Treatment Market by Geography
1.2.5.1. Global Psoriatic Arthritis Treatment Market Revenue and Growth Rate Comparison by Geography (2015-2026)
1.2.5.2. North America Psoriatic Arthritis Treatment Market Revenue and Growth Rate (2015-2026)
1.2.5.3. Europe Psoriatic Arthritis Treatment Market Revenue and Growth Rate (2015-2026)
1.2.5.4. Asia-Pacific Psoriatic Arthritis Treatment Market Revenue and Growth Rate (2015-2026)
1.2.5.5. Latin America Psoriatic Arthritis Treatment Market Revenue and Growth Rate (2015-2026)
1.2.5.6. Middle East and Africa (MEA) Psoriatic Arthritis Treatment Market Revenue and Growth Rate (2015-2026)

CHAPTER 2. MARKET DYNAMICS AND COMPETITION ANALYSIS

2.1. Market Drivers
2.2. Restraints and Challenges
2.3. Growth Opportunities
2.4. Porter’s Five Forces Analysis
2.4.1. Bargaining Power of Suppliers
2.4.2. Bargaining Power of Buyers
2.4.3. Threat of Substitute
2.4.4. Threat of New Entrants
2.4.5. Degree of Competition
2.5. Value Chain Analysis
2.6. Cost Structure Analysis
2.6.1. Raw Material and Suppliers
2.6.2. Manufacturing Process Analysis
2.7. Regulatory Compliance
2.8. Competitive Landscape, 2017
2.8.1. Player Positioning Analysis
2.8.2. Key Strategies Adopted By Leading Players

CHAPTER 3. MANUFACTURING PLANTS ANALYSIS

3.1. Capacity and Commercial Production Date of Global Psoriatic Arthritis Treatment Major Manufacturers in 2017
3.2. Manufacturing Plants Distribution of Global Psoriatic Arthritis Treatment Major Manufacturers in 2017
3.3. R&D Status and Technology Drug Class of Global Psoriatic Arthritis Treatment Major Manufacturers in 2017
3.4. Raw Materials Sources Analysis of Global Psoriatic Arthritis Treatment Major Manufacturers in 2017

CHAPTER 4. PSORIATIC ARTHRITIS TREATMENT MARKET BY DRUG CLASS

4.1. Global Psoriatic Arthritis Treatment Revenue By Drug Class
4.2. DMARD
4.2.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
4.2.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
4.3. NSAIDs
4.3.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
4.3.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
4.4. Biologics
4.4.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
4.4.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
4.5. Others
4.5.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
4.5.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)

CHAPTER 5. PSORIATIC ARTHRITIS TREATMENT MARKET BY PRODUCT TYPE

5.1. Global Psoriatic Arthritis Treatment Revenue By Product Type
5.2. OTC
5.2.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
5.2.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
5.3. Prescriptions
5.3.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
5.3.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)

CHAPTER 6. PSORIATIC ARTHRITIS TREATMENT MARKET BY ROUTE OF ADMINISTRATION

6.1. Global Psoriatic Arthritis Treatment Revenue By Route of Administration
6.2. Oral
6.2.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
6.2.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
6.3. Topical
6.3.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
6.3.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
6.4. Injectable
6.4.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
6.4.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)

CHAPTER 7. NORTH AMERICA PSORIATIC ARTHRITIS TREATMENT MARKET BY COUNTRY

7.1. North America Psoriatic Arthritis Treatment Market Revenue and Growth Rate, 2015 - 2026 ($Million)
7.2. North America Psoriatic Arthritis Treatment Market Revenue Share Comparison, 2015 & 2026 (%)
7.3. U.S.
7.3.1. U.S. Psoriatic Arthritis Treatment Market Revenue and Forecast By Drug Class, 2015 - 2026 ($Million)
7.3.2. Market Revenue and Forecast By Product Type, 2015 - 2026 ($Million)
7.3.3. Market Revenue and Forecast By Route of Administration, 2015 - 2026 ($Million)
7.4. Canada
7.4.1. Market Revenue and Forecast By Drug Class, 2015 - 2026 ($Million)
7.4.2. Market Revenue and Forecast By Product Type, 2015 - 2026 ($Million)
7.4.3. Market Revenue and Forecast By Route of Administration, 2015 - 2026 ($Million)
7.5. Mexico
7.5.1. Market Revenue and Forecast By Drug Class, 2015 - 2026 ($Million)
7.5.2. Market Revenue and Forecast By Product Type, 2015 - 2026 ($Million)
7.5.3. Market Revenue and Forecast By Route of Administration, 2015 - 2026 ($Million)

CHAPTER 8. EUROPE PSORIATIC ARTHRITIS TREATMENT MARKET BY COUNTRY

8.1. Europe Psoriatic Arthritis Treatment Market Revenue and Growth Rate, 2015 - 2026 ($Million)
8.2. Europe Psoriatic Arthritis Treatment Market Revenue Share Comparison, 2015 & 2026 (%)
8.3. UK
8.3.1. Market Revenue and Forecast By Drug Class, 2015 - 2026 ($Million)
8.3.2. Market Revenue and Forecast By Product Type, 2015 - 2026 ($Million)
8.3.3. Market Revenue and Forecast By Route of Administration, 2015 - 2026 ($Million)
8.4. Germany
8.4.1. Market Revenue and Forecast By Drug Class, 2015 - 2026 ($Million)
8.4.2. Market Revenue and Forecast By Product Type, 2015 - 2026 ($Million)
8.4.3. Market Revenue and Forecast By Route of Administration, 2015 - 2026 ($Million)
8.5. France
8.5.1. Market Revenue and Forecast By Drug Class, 2015 - 2026 ($Million)
8.5.2. Market Revenue and Forecast By Product Type, 2015 - 2026 ($Million)
8.5.3. Market Revenue and Forecast By Route of Administration, 2015 - 2026 ($Million)
8.6. Spain
8.6.1. Market Revenue and Forecast By Drug Class, 2015 - 2026 ($Million)
8.6.2. Market Revenue and Forecast By Product Type, 2015 - 2026 ($Million)
8.6.3. Market Revenue and Forecast By Route of Administration, 2015 - 2026 ($Million)
8.7. Rest of Europe
8.7.1. Market Revenue and Forecast By Drug Class, 2015 - 2026 ($Million)
8.7.2. Market Revenue and Forecast By Product Type, 2015 - 2026 ($Million)
8.7.3. Market Revenue and Forecast By Route of Administration, 2015 - 2026 ($Million)

CHAPTER 9. ASIA-PACIFIC PSORIATIC ARTHRITIS TREATMENT MARKET BY COUNTRY

9.1. Asia-Pacific Psoriatic Arthritis Treatment Market Revenue and Growth Rate, 2015 - 2026 ($Million)
9.2. Asia-Pacific Psoriatic Arthritis Treatment Market Revenue Share Comparison, 2015 & 2026 (%)
9.3. China
9.3.1. Market Revenue and Forecast By Drug Class, 2015 - 2026 ($Million)
9.3.2. Market Revenue and Forecast By Product Type, 2015 - 2026 ($Million)
9.3.3. Market Revenue and Forecast By Route of Administration, 2015 - 2026 ($Million)
9.4. Japan
9.4.1. Market Revenue and Forecast By Drug Class, 2015 - 2026 ($Million)
9.4.2. Market Revenue and Forecast By Product Type, 2015 - 2026 ($Million)
9.4.3. Market Revenue and Forecast By Route of Administration, 2015 - 2026 ($Million)
9.5. India
9.5.1. Market Revenue and Forecast By Drug Class, 2015 - 2026 ($Million)
9.5.2. Market Revenue and Forecast By Product Type, 2015 - 2026 ($Million)
9.5.3. Market Revenue and Forecast By Route of Administration, 2015 - 2026 ($Million)
9.6. Australia
9.6.1. Market Revenue and Forecast By Drug Class, 2015 - 2026 ($Million)
9.6.2. Market Revenue and Forecast By Product Type, 2015 - 2026 ($Million)
9.6.3. Market Revenue and Forecast By Route of Administration, 2015 - 2026 ($Million)
9.7. South Korea
9.7.1. Market Revenue and Forecast By Drug Class, 2015 - 2026 ($Million)
9.7.2. Market Revenue and Forecast By Product Type, 2015 - 2026 ($Million)
9.7.3. Market Revenue and Forecast By Route of Administration, 2015 - 2026 ($Million)
9.8. Rest of Asia-Pacific
9.8.1. Market Revenue and Forecast By Drug Class, 2015 - 2026 ($Million)
9.8.2. Market Revenue and Forecast By Product Type, 2015 - 2026 ($Million)
9.8.3. Market Revenue and Forecast By Route of Administration, 2015 - 2026 ($Million)

CHAPTER 10. LATIN AMERICA PSORIATIC ARTHRITIS TREATMENT MARKET BY COUNTRY

10.1. Latin America Psoriatic Arthritis Treatment Market Revenue and Growth Rate, 2015 - 2026 ($Million)
10.2. Latin America Psoriatic Arthritis Treatment Market Revenue Share Comparison, 2015 & 2026 (%)
10.3. Brazil
10.3.1. Market Revenue and Forecast By Drug Class, 2015 - 2026 ($Million)
10.3.2. Market Revenue and Forecast By Product Type, 2015 - 2026 ($Million)
10.3.3. Market Revenue and Forecast By Route of Administration, 2015 - 2026 ($Million)
10.4. Argentina
10.4.1. Market Revenue and Forecast By Drug Class, 2015 - 2026 ($Million)
10.4.2. Market Revenue and Forecast By Product Type, 2015 - 2026 ($Million)
10.4.3. Market Revenue and Forecast By Route of Administration, 2015 - 2026 ($Million)
10.5. Rest of Latin America
10.5.1. Market Revenue and Forecast By Drug Class, 2015 - 2026 ($Million)
10.5.2. Market Revenue and Forecast By Product Type, 2015 - 2026 ($Million)
10.5.3. Market Revenue and Forecast By Route of Administration, 2015 - 2026 ($Million)

CHAPTER 11. MIDDLE EAST PSORIATIC ARTHRITIS TREATMENT MARKET BY COUNTRY

11.1. Middle East Psoriatic Arthritis Treatment Market Revenue and Growth Rate, 2015 - 2026 ($Million)
11.2. Middle East Psoriatic Arthritis Treatment Market Revenue Share Comparison, 2015 & 2026 (%)
11.3. Saudi Arabia
11.3.1. Market Revenue and Forecast By Drug Class, 2015 - 2026 ($Million)
11.3.2. Market Revenue and Forecast By Product Type, 2015 - 2026 ($Million)
11.3.3. Market Revenue and Forecast By Route of Administration, 2015 - 2026 ($Million)
11.4. UAE
11.4.1. Market Revenue and Forecast By Drug Class, 2015 - 2026 ($Million)
11.4.2. Market Revenue and Forecast By Product Type, 2015 - 2026 ($Million)
11.4.3. Market Revenue and Forecast By Route of Administration, 2015 - 2026 ($Million)
11.5. Rest of Middle East
11.5.1. Market Revenue and Forecast By Drug Class, 2015 - 2026 ($Million)
11.5.2. Market Revenue and Forecast By Product Type, 2015 - 2026 ($Million)
11.5.3. Market Revenue and Forecast By Route of Administration, 2015 - 2026 ($Million)

CHAPTER 12. AFRICA PSORIATIC ARTHRITIS TREATMENT MARKET BY COUNTRY

12.1. Africa Psoriatic Arthritis Treatment Market Revenue and Growth Rate, 2015 - 2026 ($Million)
12.2. Africa Psoriatic Arthritis Treatment Market Revenue Share Comparison, 2015 & 2026 (%)
12.3. South Africa
12.3.1. Market Revenue and Forecast By Drug Class, 2015 - 2026 ($Million)
12.3.2. Market Revenue and Forecast By Product Type, 2015 - 2026 ($Million)
12.3.3. Market Revenue and Forecast By Route of Administration, 2015 - 2026 ($Million)
12.4. Egypt
12.4.1. Market Revenue and Forecast By Drug Class, 2015 - 2026 ($Million)
12.4.2. Market Revenue and Forecast By Product Type, 2015 - 2026 ($Million)
12.4.3. Market Revenue and Forecast By Route of Administration, 2015 - 2026 ($Million)
12.5. Rest of Africa
12.5.1. Market Revenue and Forecast By Drug Class, 2015 - 2026 ($Million)
12.5.2. Market Revenue and Forecast By Product Type, 2015 - 2026 ($Million)
12.5.3. Market Revenue and Forecast By Route of Administration, 2015 - 2026 ($Million)

CHAPTER 13. COMPANY PROFILE

13.1. Bristol-Myers Squibb Corporation
13.1.1. Company Snapshot
13.1.2. Overview
13.1.3. Financial Overview
13.1.4. Type Portfolio
13.1.5. Key Developments
13.1.6. Strategies
13.2. AbbVie Inc.
13.2.1. Company Snapshot
13.2.2. Overview
13.2.3. Financial Overview
13.2.4. Type Portfolio
13.2.5. Key Developments
13.2.6. Strategies
13.3. Amgen Inc.
13.3.1. Company Snapshot
13.3.2. Overview
13.3.3. Financial Overview
13.3.4. Type Portfolio
13.3.5. Key Developments
13.3.6. Strategies
13.4. Bausch Health Companies Inc.
13.4.1. Company Snapshot
13.4.2. Overview
13.4.3. Financial Overview
13.4.4. Type Portfolio
13.4.5. Key Developments
13.4.6. Strategies
13.5. Johnson & Johnson Services Inc.
13.5.1. Company Snapshot
13.5.2. Overview
13.5.3. Financial Overview
13.5.4. Type Portfolio
13.5.5. Key Developments
13.5.6. Strategies
13.6. AstraZeneca plc
13.6.1. Company Snapshot
13.6.2. Overview
13.6.3. Financial Overview
13.6.4. Type Portfolio
13.6.5. Key Developments
13.6.6. Strategies
13.7. Celgene Corporation
13.7.1. Company Snapshot
13.7.2. Overview
13.7.3. Financial Overview
13.7.4. Type Portfolio
13.7.5. Key Developments
13.7.6. Strategies
13.8. Novartis International AG
13.8.1. Company Snapshot
13.8.2. Overview
13.8.3. Financial Overview
13.8.4. Type Portfolio
13.8.5. Key Developments
13.8.6. Strategies
13.9. Pfizer Inc
13.9.1. Company Snapshot
13.9.2. Overview
13.9.3. Financial Overview
13.9.4. Type Portfolio
13.9.5. Key Developments
13.9.6. Strategies
13.10. Others
13.10.1. Company Snapshot
13.10.2. Overview
13.10.3. Financial Overview
13.10.4. Type Portfolio
13.10.5. Key Developments
13.10.6. Strategies

CHAPTER 14. RESEARCH APPROACH

14.1. Research Methodology
14.1.1. Initial Data Search
14.1.2. Secondary Research
14.1.3. Primary Research
14.2. Assumptions and Scope


Cart Summary